Advanced Cancer Diagnosis and Treatment: Second Edition
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cancer Biology and Oncology".
Deadline for manuscript submissions: 31 August 2024 | Viewed by 83
Special Issue Editors
Interests: cancer biodiagnostic; early detection of cancers; cancer biomarkers; neurobiology of olfaction; nematode biology
Special Issues, Collections and Topics in MDPI journals
Interests: pancreatic cancer; gastrointestinal cancer
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Cancer is the leading cause of death worldwide. The chances of survival increase with early cancer detection, but around half of all cancers are diagnosed at an advanced stage. Significant endeavors have been made to comprehend the mechanisms underlying cancer, create accurate and sensitive diagnostic options, and produce efficient treatments. In the last decade, advancements have been made in enhancing cancer screening programs and introducing innovative technologies to improve the early detection of cancers, with a particular focus on non-invasive methods. Novel approaches in cancer treatment are opening a new avenue for effective therapies.
Acknowledging the significant efforts made in combatting cancer, from academia to the private sector, for this Special Issue, we are seeking submissions of original research articles or reviews that present impactful advances in the development of cancer biology, diagnostics and therapeutics on one or more of, but not limited to, the following topics:
- Cancer biology;
- Molecular mechanisms of cancers;
- Cancer epigenetics;
- Mechanism of resistance to conventional therapies;
- Cancer biomarkers;
- Early detection of cancers;
- Clinical investigations;
- Diagnostics of cancers;
- Novel therapeutics;
- Novel paradigms in the diagnosis and treatment of cancers.
Dr. Takaaki Hirotsu
Prof. Dr. Hideshi Ishii
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer biology
- epigenetics
- early detection
- diagnosis
- biodiagnosis
- novel therapeutics
- new paradigms
